Table 1.
Demographics of participants.
| CCRT group (n = 12) | TAU group (n = 11) | T or χ2 | P | |
|---|---|---|---|---|
| Gender(M/F) | 7/5 | 5/6 | 0.04 | 0.84 |
| Age (years) | 39.67 ± 6.21 | 41.45 ± 3.53 | 0.84 | 0.41 |
| Education (years) | 12.08 ± 2.15 | 11.27 ± 1.68 | 1.00 | 0.33 |
| Illness duration (years) | 16.30 ± 7.41 | 18.55 ± 5.37 | 0.80 | 0.43 |
| Onset age | 24.3 ± 4.47 | 22.36 ± 5.75 | 0.86 | 0.40 |
| Risperidone | 2 | 7 | ||
| Clozapine | 3 | 3 | ||
| Olanzapine | 4 | 2 | ||
| Sulpiride | 1 | 1 | ||
| Quetiapine | 3 | 1 | ||
| Ziprasidone | 2 | 0 | ||
| Perphenazine | 1 | 0 | ||
| Dose of antipsychotic medication (Chlorpromazine- equivalent mg/day) | 553.90 ± 253.57 | 421.98 ± 189.68 | 1.402 | 0.176 |
Note: TAU = treatment-as-usual; CCRT = computerized cognitive remediation therapy PANSS = Positive and Negative Syndrome Scale.